Ceritinib

A summary of the most common chemical descriptors (InChI Key and SMILES codes) for Ceritinib are summarized together with 3D and 2D structures and relevant physico-chemical properties.

What is the Ceritinib?

The molecule Ceritinib presents a molecular formula of C28H36ClN5O3S and its IUPAC name is 5-chloro-2-N-(5-methyl-4-piperidin-4-yl-2-propan-2-yloxyphenyl)-4-N-(2-propan-2-ylsulfonylphenyl)pyrimidine-2,4-diamine.

Ceritinib (LDK378) is a drug used to treat non-small cell lung cancer (NSCLC). It is a kinase inhibitor that targets the anaplastic lymphoma kinase (ALK) protein. Ceritinib was approved by the United States Food and Drug Administration (FDA) in April 2014, and by the European Medicines Agency (EMA) in June 2014..

Ceritinib was developed by the pharmaceutical company Novartis. The drug was originally designed to treat ALK-positive NSCLC, a subtype of NSCLC that represents around 5% of all NSCLC cases. In clinical trials, ceritinib was found to be effective in treating ALK-positive NSCLC that had progressed after treatment with crizotinib, another ALK inhibitor..

Ceritinib exists in the United States as a 150 mg tablet. The recommended dose is 750 mg once daily. Ceritinib should be taken on an empty stomach, at least 1 hour before or 2 hours after a meal..

Common side effects of ceritinib include diarrhea, nausea, vomiting, fatigue, and decreased appetite. Ceritinib can also cause QT prolongation, a condition that can lead to irregular heartbeats..

Ceritinib is a potent and specific inhibitor of the ALK protein. In preclinical studies, ceritinib was found to inhibit the growth of ALK-positive NSCLC cell lines. Ceritinib has also been shown to cross the blood-brain barrier, which is important for the treatment of brain metastases..

Ceritinib is the first ALK inhibitor to be approved for the treatment of NSCLC. Clinical trials have shown that ceritinib is effective in treating ALK-positive NSCLC that has progressed after treatment with crizotinib. Ceritinib is generally well tolerated, with the most common side effects being diarrhea, nausea, vomiting, and fatigue..

3D structure

Cartesian coordinates

Geometry of Ceritinib in x, y and z coordinates (Å units) to copy/paste elsewhere. Generated with Open Babel software.

2D drawing

 

Ceritinib VERWOWGGCGHDQE-UHFFFAOYSA-N chemical compound 2D structure molecule svg
Ceritinib

 

Molecule descriptors

 
IUPAC name5-chloro-2-N-(5-methyl-4-piperidin-4-yl-2-propan-2-yloxyphenyl)-4-N-(2-propan-2-ylsulfonylphenyl)pyrimidine-2,4-diamine
InChI codeInChI=1S/C28H36ClN5O3S/c1-17(2)37-25-15-21(20-10-12-30-13-11-20)19(5)14-24(25)33-28-31-16-22(29)27(34-28)32-23-8-6-7-9-26(23)38(35,36)18(3)4/h6-9,14-18,20,30H,10-13H2,1-5H3,(H2,31,32,33,34)
InChI KeyVERWOWGGCGHDQE-UHFFFAOYSA-N
SMILESCc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1

Other names (synonyms)

IUPAC nomenclature provides a standardized method for naming chemical compounds. Although this system is widely used in chemistry, many chemical compounds have also other names commonly used in different contexts. These synonyms can come from a variety of sources and are used for a variety of purposes.

One common source of synonyms for chemical compounds is the common or trivial names, assigned on the basis of appearance, properties, or origin of the molecule.

Another source of synonyms are historical or obsolete names employed in the past, however replaced nowadays by more modern or standardized names.

In addition to common and historical names, chemical compounds may also have synonyms that are specific to a particular field or industry.

  • 1032900-25-6
  • 2,4-Pyrimidinediamine, 5-chloro-N4-(2-((1-methylethyl)sulfonyl)phenyl)-N2-(5-methyl-2-(1-methylethoxy)-4-(4-piperidinyl)phenyl)-
  • 4MK
  • 5-CHLORO-N2-(5-METHYL-4-(PIPERIDIN-4-YL)-2-(PROPAN-2-YLOXY)PHENYL)-N4-(2-(PROPANE-2- SULFONYL)PHENYL)PYRIMIDINE-2,4-DIAMINE
  • 5-CHLORO-N4-(2-((1-METHYLETHYL)SULFONYL)PHENYL)-N2-(5-METHYL-2-(1-METHYLETHOXY)-4- (PIPERIDIN-4-YL)PHENYL)PYRIMIDINE-2,4-DIAMINE
  • 5-Chloro-N2-(2-isopropoxy-5-methyl-4-piperidin-4-yl-phenyl)-N4-[2-(propane-2-sulfonyl)-phenyl]-pyrimidine-2,4-diamine
  • 5-Chloro-N2-(5-methyl-4-(piperidin-4-yl)-2-(propan-2-yloxy)phenyl)-N4-(2-(propane-2-sulfonyl)phenyl)pyrimidine-2,4-diamine
  • 5-Chloro-N2-[2-isopropoxy-5-Methyl-4-(4-piperidyl)phenyl]-N4-(2-isopropylsulfonylphenyl)pyriMidine-2,4-diaMine
  • 5-Chloro-N4-[2-[(1-methylethyl)sulfonyl]phenyl]-N2-[5-methyl-2-(1-methylethoxy)-4-(4-piperidinyl)phenyl]-2,4-pyrimidinediamine
  • 5-Chloro-N4-[2-[(1methylethyl)sulfonyl]phenyl]-N2-[5-methyl-2-(1-methylethoxy)-4-(4-piperidinyl)phenyl]-2,4-pyrimidinediamine;5-Chloro-N4-[2-[(1methylethyl)sulfonyl]phenyl]-N2-[5-methyl-2-(1-methylethoxy)-4-(4-piperidinyl)phenyl]-2,4-pyrimidinediamine
  • 5-Chloro-N~2~-[5-Methyl-4-(Piperidin-4-Yl)-2-(Propan-2-Yloxy)phenyl]-N~4~-[2-(Propan-2-Ylsulfonyl)phenyl]pyrimidine-2,4-Diamine
  • 5-chloro-2-N-(5-methyl-4-piperidin-4-yl-2-propan-2-yloxyphenyl)-4-N-(2-propan-2-ylsulfonylphenyl)pyrimidine-2,4-diamine
  • 5-chloro-2-N-[5-methyl-4-(piperidin-4-yl)-2-(propan-2-yloxy)phenyl]-4-N-[2-(propane-2-sulfonyl)phenyl]pyrimidine-2,4-diamine
  • 5-chloro-N(2)-{5-methyl-4-(piperidin-4-yl)-2-[(propan-2-yl)oxy]phenyl}-N(4)-[2-(propane-2-sulfonyl)phenyl]pyrimidine-2,4-diamine
  • 5-chloro-N2-(2-isopropoxy-5-methyl-4-(piperidin-4-yl)phenyl)-N4-(2-(isopropylsulfonyl)phenyl)pyrimidine-2,4-diamine
  • 5-chloro-N2-[5-methyl-4-(piperidin-4-yl)-2-(propan-2-yloxy)phenyl]-N4-[2-(propane-2-sulfonyl)phenyl]pyrimidine-2,4-diamine
  • A852144
  • AC-27469
  • AMY10314
  • BCP07611
  • BDBM50436850
  • CCG-264762
  • CS-1406
  • Ceritinib
  • Ceritinib (JAN/USAN/INN)
  • Ceritinib (LDK378)
  • Ceritinib(LDK378)
  • Ceritinib; LDK378
  • Ceritinib;5-Chloro-N2-[2-isopropoxy-5-Methyl-4-(4-piperidyl)phenyl]-N4-(2-isopropylsulfonylphenyl)pyriMidine-2,4-diaMine;Ceritinib
  • D10551
  • DB09063
  • EX-A187
  • Eritinib (LDK378)
  • FT-0697208
  • GS-6356
  • GTPL7397
  • HMS3652H22
  • HMS3673I17
  • HMS3747A11
  • HY-15656
  • J-690011
  • K418KG2GET
  • LDK 378
  • LDK-378
  • LDK378
  • LDK378 Certinib
  • LDK378(Ceritinib)
  • MFCD26142648
  • N-{2-Methyl-5-[(methylamino)methyl]phenyl}-4-[(4-phenyl-2-quinazolinyl)amino]benzamide
  • N-{2-[(5-chloro-2-{[2-isopropoxy-5-methyl-4-(piperidin-4-yl)phenyl]amino}pyrimidin-4-yl)amino]phenyl}propane-2-sulfonamide
  • NCGC00351603-10
  • NCGC00351603-13
  • NCGC00351603-15
  • NSC-776422
  • NSC-777193
  • NSC-800072
  • NSC776422
  • NSC777193
  • NSC800072
  • NVP-LDK-378-NX
  • NVP-LDK378-NX
  • Q21011233
  • S7083
  • SB16490
  • SW219725-1
  • ZYKADIA
  • ceritinib
  • ceritinibum

Reference codes for other databases

There exist several different chemical codes commonly used in orded to identify molecules:
  • ZINC96272772
  • UNII-K418KG2GET
  • AKOS025396438
  • DTXSID10725373
  • CHEMBL2403108
  • CHEBI:78432
  • SCHEMBL1014329

Physico-Chemical properties

IUPAC name5-chloro-2-N-(5-methyl-4-piperidin-4-yl-2-propan-2-yloxyphenyl)-4-N-(2-propan-2-ylsulfonylphenyl)pyrimidine-2,4-diamine
Molecular formulaC28H36ClN5O3S
Molecular weight558.135
Melting point (ºC)
Boiling point (ºC)
Density (g/cm3)
Molar refractivity158.71
LogP7.9
Topological polar surface area113.6

LogP and topological polar surface area (TPSA) values were estimated using Open Babel software.

The n-octanol/water partition coeficient (Kow) data is applied in toxicology and drug research. Kow values are used, to guess the environmental fate of persistent organic pollutants. High partition coefficients values, tend to accumulate in the fatty tissue of organisms. Molecules with a log(Kow) (or LogP) greater than 5 are considered to bioaccumulate.

TPSA values are the sum of the surface area over all polar atoms or molecules, mainly oxygen and nitrogen, also including hydrogen atoms.

In medicinal chemistry, TPSA is used to assess the ability of a drug to permeabilise cells.

For molecules to penetrate the blood-brain barrier (and act on receptors in the central nervous system), TPSA values below 90 Å2 are required. Thus, molecules with a polar surface area greater than 140 Å2 tend to be poorly permeable to cell membranes.